In the memo released by the FDA during the discovery process, Dr. Curtis Rosebraugh, an agency medical officer, wrote: "As an example, she stated that we could not anticipate, or prevent extreme promiscuous behaviors such as the medication taking on an 'urban legend' status that would lead adolescents to form sex-based cults centered around the use of Plan B."
Conservative groups contend Plan B causes abortions and have lobbied against non-prescription sales. The manufacturer, Barr Laboratories of Pomona, N.Y., says it simply prevents pregnancy.
The FDA rejected Barr's application for Plan B non-prescription sales in May 2004. On May 6, 2004, Galson, now head of the FDA drug center, wrote in a memo: "Some staff have expressed the concern that this decision is based on non-medical implications of teen sexual behavior, or judgments about the propriety of this activity. These issues are beyond the scope of our drug approval process, and I have not considered them in this decision."